Physicians show ‘strong demand’ for the neurostimulator for obstructive sleep apnea patients, says Nyxoah CEO.| Sleep Review
Insights from a retrospective review of children who underwent hypoglossal nerve stimulator implant surgeries.| Sleep Review
The USPTO has awarded Nexalin Technology Inc a new patent relating to its method of use, which covers key aspects of the technology that enables patients to receive treatment from the privacy of their homes.| Sleep Review